ACADIA Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.About ACAD
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
ACAD Key Statistics
Stock Snapshot
The current ACADIA Pharmaceuticals(ACAD) stock price is $20.25, with a market capitalization of 3.46B. The stock trades at a price-to-earnings (P/E) ratio of 8.98.
On 2026-10-06, ACADIA Pharmaceuticals(ACAD) stock traded between a low of $19.57 and a high of $20.50. Shares are currently priced at $20.25, which is +3.5% above the low and -1.2% below the high.
ACADIA Pharmaceuticals(ACAD) shares are trading with a volume of 3.15M, against a daily average of 3.05M.
In the last year, ACADIA Pharmaceuticals(ACAD) shares hit a 52-week high of $30.96 and a 52-week low of $19.57.
In the last year, ACADIA Pharmaceuticals(ACAD) shares hit a 52-week high of $30.96 and a 52-week low of $19.57.
ACAD News
...
Investment firm RBC said the patent litigation between Acadia Pharmaceuticals (ACAD) and generic drugmaker Zydus over Nuplazid appears to have been resolved. S...
If you had backed Acadia Pharmaceuticals at the very start of 2026, the outcome so far would have stung. Holding Acadia Pharmaceuticals from the start of the ye...
Analyst ratings
75%
of 20 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.